WINDTREE THERAPEUTICS INC (WINT) Fundamental Analysis & Valuation
NASDAQ:WINT • US97382D6004
Current stock price
0.11 USD
-0.37 (-77.21%)
At close:
0.1048 USD
-0.01 (-4.73%)
After Hours:
This WINT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. WINT Profitability Analysis
1.1 Basic Checks
- In the past year WINT has reported negative net income.
- In the past year WINT has reported a negative cash flow from operations.
- In the past 5 years WINT always reported negative net income.
- In the past 5 years WINT always reported negative operating cash flow.
1.2 Ratios
- WINT has a worse Return On Assets (-77.52%) than 65.81% of its industry peers.
- WINT's Return On Equity of -183.17% is on the low side compared to the rest of the industry. WINT is outperformed by 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.52% | ||
| ROE | -183.17% | ||
| ROIC | N/A |
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for WINT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. WINT Health Analysis
2.1 Basic Checks
- The number of shares outstanding for WINT has been increased compared to 1 year ago.
- The number of shares outstanding for WINT has been increased compared to 5 years ago.
- Compared to 1 year ago, WINT has an improved debt to assets ratio.
2.2 Solvency
- WINT has an Altman-Z score of -47.63. This is a bad value and indicates that WINT is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -47.63, WINT is not doing good in the industry: 92.65% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.01 indicates that WINT is not too dependend on debt financing.
- The Debt to Equity ratio of WINT (0.01) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -47.63 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.25 indicates that WINT may have some problems paying its short term obligations.
- WINT's Current ratio of 0.25 is on the low side compared to the rest of the industry. WINT is outperformed by 94.85% of its industry peers.
- A Quick Ratio of 0.25 indicates that WINT may have some problems paying its short term obligations.
- WINT has a worse Quick ratio (0.25) than 94.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.25 | ||
| Quick Ratio | 0.25 |
3. WINT Growth Analysis
3.1 Past
- The earnings per share for WINT have decreased strongly by -236.14% in the last year.
EPS 1Y (TTM)-236.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 14.49% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. WINT Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for WINT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WINT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- WINT's earnings are expected to grow with 25.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.23%
EPS Next 3Y25.96%
5. WINT Dividend Analysis
5.1 Amount
- No dividends for WINT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
WINT Fundamentals: All Metrics, Ratios and Statistics
0.11
-0.37 (-77.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-18 2025-08-18/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners1.23%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner Change0%
Market Cap3.23M
Revenue(TTM)N/A
Net Income(TTM)-20.75M
Analysts43.33
Price Target180.54 (164027.27%)
Short Float %0.01%
Short Ratio0
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-3.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.28 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-400
EYN/A
EPS(NY)-2.2
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0
BVpS0.39
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.52% | ||
| ROE | -183.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.25 | ||
| Quick Ratio | 0.25 | ||
| Altman-Z | -47.63 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)55.35%
Cap/Depr(5y)88.07%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.42%
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.92%
OCF growth 3YN/A
OCF growth 5YN/A
WINDTREE THERAPEUTICS INC / WINT Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for WINDTREE THERAPEUTICS INC?
ChartMill assigns a fundamental rating of 1 / 10 to WINT.
What is the valuation status for WINT stock?
ChartMill assigns a valuation rating of 1 / 10 to WINDTREE THERAPEUTICS INC (WINT). This can be considered as Overvalued.
How profitable is WINDTREE THERAPEUTICS INC (WINT) stock?
WINDTREE THERAPEUTICS INC (WINT) has a profitability rating of 0 / 10.
How financially healthy is WINDTREE THERAPEUTICS INC?
The financial health rating of WINDTREE THERAPEUTICS INC (WINT) is 1 / 10.
How sustainable is the dividend of WINDTREE THERAPEUTICS INC (WINT) stock?
The dividend rating of WINDTREE THERAPEUTICS INC (WINT) is 0 / 10 and the dividend payout ratio is -3.6%.